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Abstract 
Background: The role of the microenvironment is 
important in cell differentiation. The effect of 
placental disease on the growth and 
differentiation and hematopoietic stem cells has 
not been well-studied.   
Methods: Enzyme linked immunoassay was 
used to measure erythropoietin and osteopontin 
in plasma from umbilical cord blood of children 
born to normotensive and preeclamptic women. 
Additionally, CD34+ cells were isolated from 
umbilical cord blood and grown in complete 
methylcellulose media. Colony types were 
identified and enumerated. 
Results: Differences in the concentration of 
erythropoietin in the cord blood between the 
controls and the preeclamptics approached 
significance (P = 0.067) using a Mann-Whitney 
U test. In the plasma of cord blood from children 
born to normotensive women, the median 
erythropoietin was 0.186 mIU/mL compared to 
1.986 mIU/mL in children of preeclamptic 
women. We did not find any significant 
differences in the number and types of colonies; 
however, there was a trend toward increased 
BFU-E in the preeclamptic samples. 
Furthermore, this trend for increased BFU-E 
colonies was also seen from CD34+ cells 
isolated from umbilical cord blood of severe 
preeclamptics compared to mild.  
Conclusion:  Our preliminary studies suggest 
that abnormalities in the placenta, such as those 
found when the mother experiences 
preeclampsia, may affect the ability of 
hematopoietic stem cells to grow and 
differentiate.  
1Division of Reproductive Science Research, 
and 2Division of Maternal Fetal Medicine, The 
Department of Obstetrics and Gynecology, 3Roy 
J. and Lucille A. Carver College of Medicine, 
The University of Iowa, Iowa City, Iowa, USA. 
Background 
The regulation of the growth and 
differentiation of hematopoietic stem 
cells during development is quite 
complex. The role of the placenta in 
hematopoiesis is not yet well 
understood.  Although the placenta has 
been shown to be a site of definitive 
hematopoiesis, it is unclear what impact 
placental disease has on hematopoietic 
stem cells and if there are any short or 
long-term ramifications to the child. To 
begin to address this question, we have 
measured cytokines from the umbilical 
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cord blood of pregnancies with a normal 
placenta in comparison to an abnormal 
placenta.  As placental insufficiencies 
are well described in preeclampsia, we 
have used this disease as our model of 
an abnormal placenta in our study of 
cytokines and cell growth.  
Cytokines, growth factors, and 
chemokines are all well-known 
regulators of hematopoiesis. However, 
in vitro hematopoietic stem cell 
differentiation and expansion 
experiments demonstrate that there are 
other, less-well understood factors that 
also exert control of cell growth and 
differentiation.  The in vivo cellular 
microenvironment may provide a critical 
influence over the cells. This 
microenvironment can be altered in the 
face of pregnancy-related diseases, 
such as preeclampsia. Preeclampsia is 
a disease of pregnancy in which 
parturients develop hypertension, 
proteinuria, and potential seizures, liver 
and kidney failure.  
In preeclampsia, there are significant 
abnormalities in the placenta such as 
abnormal cytotrophoblast differentiation, 
shallow trophoblast invasion, and 
decreased blood flow to and from the 
placenta.  Multiple studies of 
preeclampsia have found increased 
apoptosis in cytotrophoblasts1,2  
Kadyrov confirmed an increased rate of 
apoptosis in trophoblast cells of spiral 
artery walls.2  Since spiral arteries are of 
maternal origin, it is likely that a 
maternal signal is promoting the 
apoptosis. The apoptotic signal may 
come from maternal macrophages near 
the spiral arteries. Large numbers of 
macrophages were seen in vessel 
cross-sections from preeclamptic 
women; however, macrophages were 
rare in sections from normal 
pregnancies.3 Furthermore, necrosis 
may occur as a result of aberrant 
trophoblast cell differentiation.  Such 
necrosis of trophoblasts results in the 
release of cell fragments into the 
maternal bloodstream.  These 
fragments are readily detected in 
preeclamptic maternal peripheral blood 
and may trigger an inflammatory 
response.4,5,6 
Several studies point to differences in 
hematopoietic cell populations observed 
in children born to preeclamptic and 
normotensive mothers. Using flow 
cytometry, Surbek et al. demonstrated 
that the fetal cord blood of preeclamptic 
women contained fewer CD34+ positive 
cells (p=0.023) compared to the control 
group.7 In addition, they found that 
samples from preeclamptic patients 
produced fewer colony forming units in 
erythropoietin and mixed growth factor–
stimulated in vitro differentiation assays. 
A study by Stallmach et al. found less 
erythroid precursors and early 
granulopoietic cells in fetal livers of 
preeclamptic affected pregnancies.8  
There is not a clear understanding of 
whether there are altered signaling 
mechanisms affecting fetal 
hematopoiesis in preeclampsia.  Several 
possibilities exist including differences in 
cytokines and growth factors that can 
affect the growth and differentiation 
potential of cells.  A recent study found 
significantly higher levels of leukemia 
inhibitory factor in placentas of 
preeclamptic women compared to well-
matched normotensive controls.9 
Additionally, differences in osteopontin 
localization have been demonstrated in 
preeclamptic placentas.10 As 
osteopontin has biological functions in 
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cell survival, angiogenesis, and immune 
function, aberrant localization may have 
secondary effects on cells in their 
microenvironment. 
Another potential mechanism affecting 
fetal hematopoiesis, demonstrated in 
mice, involves the placenta as a 
hematopoietic organ.11,12,13 Because 
there is incomplete placentation in 
preeclampsia, this may contribute to the 
observed differences by leading to a 
reduced number of hematopoietic 
progenitors. A reduction in the number 
of hematopoietic progenitors may be 
responsible for the decrease in CD3+, 
CD4+, and CD8+CD28+ lymphocytes 
that has been observed in neonates 
born to mothers with severe 
preeclampsia.14  
In this preliminary investigation, our 
objective was to determine if any 
functional differences exist in signaling 
by analyzing the in vitro differentiation 
potential of hematopoietic progenitors 
isolated from umbilical cord blood from 
babies born to women with 
preeclampsia compared to those born to 
normotensive women. In addition, we 
sought to identify differences in 
cytokines in the cord blood samples.  
Methods 
Study subjects and sample collection 
Patient specimens were obtained 
through user agreements with the 
Institutional Review Board – approved 
Hematopoietic Stem Cell Bank and the 
Maternal Fetal Tissue Bank at the 
University of Iowa. Umbilical cord blood 
samples were collected from 15 women 
with mild and severe preeclampsia that 
delivered at term (>37 weeks). The 
diagnosis of mild preeclampsia is made 
when a pregnant woman has a 
persistent blood pressure of 140 mm Hg 
systolic or higher or 90 mm Hg diastolic 
or higher that occurs after 20 weeks of 
gestation on 2 occasions 6 hours apart 
in a woman with previously normal 
blood pressures and proteinuria, defined 
as urinary excretion of 0.3 g protein or 
higher in a 24-hour urine specimen. 
Severe preeclampsia is defined by a 
systolic blood pressure >160 mm Hg or 
a diastolic blood pressure >110 mm Hg 
on at least 2 occasions >6 hours apart 
and 3-4+ proteinuria, or HELLP 
syndrome (severe preeclampsia with 
hemolysis, elevated liver enzymes, and 
low platelet count). Samples from a 
control group of 18 women with normal 
pregnancies were also obtained. 
Exclusion criteria included maternal 
chronic hypertension, known preexisting 
microvascular disease, and diabetes 
mellitus. Exclusion criteria of the 
Hematopoietic Stem Cell Bank and the 
Maternal Fetal Tissue Bank are 
maternal age less than 18 years old, 
HIV+, Hepatitis C+, inability to provide 
informed consent, and non-English 
speaking.  
Plasma Isolation 
Cord blood was collected as described 
above. Plasma was isolated using a 
Plasma Separator Tube (Becton 
Dickinson) per the manufacturer’s 
recommendations. Plasma was 
immediately aliquoted, snap frozen, and 
stored at -80 oC until analysis.  
Cytokine Analysis 
Erythropoietin (EPO) and osteopontin 
(OPN) in the plasma of umbilical cord 
blood were analyzed using a 
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commercially available ELISA assays 
(Platinum assays from eBioscience). All 
samples were analyzed in duplicate and 
the average of the samples was used to 
calculate the EPO and OPN 
concentrations. Manufacturer’s 
protocols were followed for these 
assays.  
Cell Isolation and culture 
Cord blood was collected at delivery into 
Citrate Phosphate Dextrose Solution 
(Fenwal Technologies).  CD34+ cells 
were isolated by immunomagnetic 
selection (StemSep, Stem Cell 
Technologies) from freshly collected 
umbilical cord blood from a subset of 
patients (8 Preeclamptics, 5 
normotensive women). 500 cells from 
each sample were plated in duplicate in 
complete methylcellulose media 
(Methocult, Stem Cell Technologies) 
and incubated for 16 days at 37oC in 5% 
CO2. Colonies were identified and 
enumerated by visual inspection. Colony 
types that are expected to arise in this 
assay include colony-forming unit-
erythroid (CFU-E), burst forming unit-
erythroid (BFU-E), colony forming unit-
granulocyte, macrophage (CFU-GM), 
and colony forming unit-granulocyte, 
erythroid, macrophage, megakaryocyte 
(CFU-GEMM).  
Statistical Analysis 
All statistical analyses were performed 
with SigmaStat 3.0 software (Systat 
Software, Inc, California).  Descriptive 
statistics were used to characterize the 
data. In addition, the Fisher exact test 
was utilized for dichotomous variables. 
For continuous variables, the 2-tailed t 
test or if criteria for normality were not 
met, the non-parametric Mann-Whitney 
U test was utilized.  All variables were 
tested at significance level of 0.05. 
Table 1. Maternal Demographics 
Characteristic Control 
(mean or 
median)  
N=18 
Preeclamptic 
(mean or 
median) 
N=15 
P 
value 
Age 29.9 28.6 0.26a 
BMI 29.1 33.7 0.10a 
Gravida 2 2 0.97b 
% Caucasian 88.9% 93.8% 1.0c 
a2-tailed t test 
bMann Whitney U 
cFisher Exact Test 
 
Results 
We began our studies by examining 
differences in cytokine signaling 
between the preeclamptic and 
normotensive cord blood (N=15 and 
N=18, respectively). Table 1 
demonstrates that there were no 
significant differences in the age, body 
mass index, gravida, or percentage of 
Caucasians between these two groups 
of patients. In analyzing characteristics 
of their pregnancies, no differences 
were found in the percentage of 
multiples, GBS positive, diabetics, the 
gestational age at delivery, the rate of 
cesarean section, or birthweight.  From 
these very similar groups, differences in 
the concentration of erythropoietin in the 
cord blood between the controls and the 
preeclamptics approached significance 
(P = 0.067) in a Mann-Whitney U. In the 
plasma of cord blood from children born 
to normotensive women, the median 
EPO was 0.186 mIU/mL compared to 
1.986 mIU/mL in children of 
preeclamptic women (Figure 1).
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Figure 1.  Erythropoietin concentration in umbilical cord blood plasma. 
One marker of fetal well-being at birth is 
the Apgar score.  Because there was a 
significant difference in the 1 min Apgar 
between groups (Table 2), we were also 
interested in whether there was in a 
difference in osteopontin concentrations 
in the cord blood samples between 
groups. Maternal plasma osteopontin 
has shown to be altered in women with 
preeclampsia who have extensive 
endothelial damage.15  We wanted to 
determine whether these differences are 
also found in the plasma of umbilical 
cord blood. Interestingly, we found a 
statistically significant increase in the 
concentration of osteopontin in the 
plasma of umbilical cord blood of 
children born to preeclamptic women 
compared to those born to normotensive 
women (44.65±2.5ng/ml versus 
35.96±2.59ng/ml  P = 0.022) (Figure 2).  
As osteopontin is also an inhibitor of 
hematopoietic stem cells,16 we were 
also interested in whether differences in 
colony sizes could be attributed to 
differences in osteopontin.  
Table 2. Pregnancy Characteristics 
Characteristic Control 
(% or 
mean) 
Preeclamptic 
(% or mean) 
P value 
Multiples 11.1 18.8 0.26a 
GBS positive 41.2 14.3 0.13a 
Diabetes 5.9 6.7 1.0a 
Gestational 
Age at 
Delivery 
37 2/7 
weeks 
36 6/7 weeks 0.54b 
C-Section 44.4% 53.3% 0.874a 
Birthweight 
(grams) 
2921.2 2913.7 0.98b 
1 min 
APGAR 
9 8 0.002c 
a2-tailed t test 
bMann Whitney U 
cFisher Exact Test 
 
As other groups have reported a 
difference in erythropoietin and we saw 
a trend toward an increase in EPO in 
preeclamptics, we sought to determine 
whether in a subset of preeclamptic and 
normotensive patients if there was a 
difference in the differentiation potential 
of the umbilical cord stem cells when 
grown in methylcellulose in complete 
medium with identical cytokine 
concentrations. We did not find any 
significant differences in the number and 
types of colonies; however, there was a 
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trend toward increased BFU-E in the 
preeclamptic samples (Figure 3). 
Furthermore, this trend for increased 
BFU-E colonies was also seen from 
CD34+ cells isolated from umbilical cord 
blood of severe preeclamptics 
compared to mild (Figure 4). More 
subjectively, colonies of all types were 
consistently found to be smaller in size 
in the colony assay of the preeclamptic 
samples (Figure 5). 
 
Figure 2.  Osteopontin concentration in umbilical cord blood plasma. *2-tailed t 
test P = 0.02 vs. control. 
As an equal number of cells were plated 
per sample, differences in colony count 
were not due to initial cell number. 
However, as other groups have found a 
difference in the number of 
hematopoietic progenitors and cord 
volume collected between samples from 
preeclamptic and normotensive 
mothers, we also addressed this 
question.  No significant differences 
were found in the number of CD34+ 
cells collected or in the volume of cord 
blood collected. As shown in Table 3, 
the average total number of CD34+ cells 
was 4.7 x 105 from normotensive 
pregnancies compared to 5.5 x 105 from 
preeclamptic pregnancies (P = 0.80). 
The average volume of cord blood 
collected was 99.6ml in normotensive 
pregnancies and 75.8ml in preeclamptic 
pregnancies (P = 0.15). 
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Figure 3.  In vitro differentiation of CD34+ umbilical cord blood cells.  Cell from the 
umbilical cord blood of children born to normotensive women represented by yellow 
bars and from preeclamptic women in grey. 
 
Discussion 
The fairly recent identification of the 
placenta as a site of definitive 
hematopoiesis raises many intriguing 
questions, including what are the effects 
of placental disease on the 
hematopoietic stem cells that arise there 
and whether this leads to any effects on 
the child. To begin to address these 
questions, we sought to understand 
whether there were differences in 
cytokine signals for cell growth and 
differentiation and whether 
hematopoietic stem cells isolated from 
the umbilical cord of children born to 
normotensive and preeclamptic women 
had any differences in differentiation 
potential in vitro.   
One of the most well-defined 
mechanisms to alter cell differentiation 
is through cytokine signaling. In the 
case of erythroid cells, erythropoietin 
(EPO) is critically important. Therefore, 
we began our investigation by 
measuring EPO. Unlike other studies, 
we did not detect a statistically 
significant difference in EPO, although 
we did identify a trend toward increased 
EPO in cord blood of children born to 
preeclamptic women (Figure 1).17 Our 
results may not have reached 
significance because of the smaller 
sample size in our study compared to 
others.  Our result suggests that it is 
unlikely that increased EPO alone is 
driving progenitor cells into erythroid 
cells. Given the role of osteopontin in 
regulating stem cell expansion and its 
elevation in preeclamptics women with 
extensive endothelial damage, we also 
measured OPN in the plasma of our 
umbilical cord blood samples. 
Interestingly, while OPN was not 
different in the maternal plasma of 
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normotensive and preeclamptics by 
others, we found an increase in the 
plasma of cord blood of preeclamptics 
without regard to the severity of the 
preeclampsia. Therefore, this increase 
in OPN in cord blood plasma may be a 
reflection of the suppression of the stem 
cells rather than of endothelial damage 
in the child. 
 
Figure 4. Comparison of in vitro differentiation of CD34+ cells from the umbilical 
cord blood of mild (dark red bars) and severe preeclamptics (blue bars). 
 
Figure 5.  Colonies from preeclamptic samples appeared smaller in the colony 
assay. 
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Table 3. Sample Characteristics 
Characteristic Control Preeclamptic P value 
Average cord blood 
volume collected  
99.6ml 75.8ml 0.15a 
Average number of 
CD34+ cells isolated  
4.7 x 105 5.5 x 105 0.75a 
a2-tailed t test 
 
Although there tended to be more 
erythroid precursors from the severe 
preeclamptic samples compared to the 
mild preeclamptic samples, the 
difference was not statistically 
significant.  To clarify if the CD34+ cells 
isolated from the cord blood of 
preeclamptic and normotensive women 
would form the same colonies in vitro 
under conditions in identical growth 
media for cells, we began by analyzing 
umbilical cord blood to determine if 
there is a difference; however, this 
sample would contain hematopoietic 
stem cells generated by all sites of 
definitive hematopoiesis. As others have 
described differences in the cord blood 
cells of preeclamptics, we wanted to 
begin our investigation with these 
cells.7,14,18  Given that with this mixed 
population we began to see differences 
in colonies, it would be interesting to 
isolate hematopoietic stem cells from 
placental tissue and to determine if this 
pool of cells specifically has an aberrant 
differentiation and growth potential in 
diseased placenta, such as in 
preeclampsia. Additionally, it would be 
informative to perform the colony assay 
under hypoxic conditions to determine if 
low oxygen conditions affect the 
differentiation potential of the CD34+ 
cells.   
While not statistically significant, the 
trend toward an increased propensity to 
differentiate into erythroid precursors in 
cases of severe preeclampsia is 
interesting. In preeclampsia, the 
placenta is in a hypoxic state due to 
incomplete remodeling of the spiral 
arteries.  We hypothesize that cells are 
primed to differentiate into erythroid 
cells to compensate for the hypoxia. 
Future studies will further explore this 
hypothesis. 
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